Prevalence and risk factors of hepatocellular carcinoma in Japanese patients with primary biliary cirrhosis-Reference-Cited by-同舟云学术

Prevalence and risk factors of hepatocellular carcinoma in Japanese patients with primary biliary cirrhosis

Published:2013-11-08 Issue:2 Volume:44 Page:133-140
ISSN:1386-6346
Container-title:Hepatology Research
language:en
Short-container-title:Hepatol Res

Author:

Harada Kenichi¹,Nakanuma Yasuni¹

Affiliation:

1. Department of Human Pathology; Kanazawa University School of Medicine; Kanazawa Japan

Publisher

Wiley

Subject

Infectious Diseases,Hepatology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/hepr.12242/fullpdf

Reference32 articles.

1. Incidence of and risk factors for hepatocellular carcinoma in primary biliary cirrhosis: national data from Japan;Harada;Hepatology,2013

2. Risk of hepatocellular carcinoma and extrahepatic malignancies in primary biliary cirrhosis;Deutsch;Eur J Gastroenterol Hepatol,2008

3. Primary biliary cirrhosis and cancer risk: a systematic review and meta-analysis;Liang;Hepatology,2012

4. Incidence of hepatic and extra-hepatic malignancies in primary biliary cirrhosis (PBC);Floreani;Ital J Gastroenterol,1993

5. Hepatocellular carcinoma in primary biliary cirrhosis: similar incidence to that in hepatitis C virus-related cirrhosis;Caballeria;Am J Gastroenterol,2001

Cited by 16 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Current Perspectives on the Molecular and Clinical Relationships between Primary Biliary Cholangitis and Hepatocellular Carcinoma;International Journal of Molecular Sciences;2024-02-12

2. Risk factors for cancer in patients with primary biliary cholangitis and autoimmune hepatitis and primary biliary cholangitis overlap syndrome;Annals of Hepatology;2023-07

3. Challenges for diagnosis and treatment of primary biliary cholangitis;Translational Autoimmunity;2023

4. APASL clinical practice guidance: the diagnosis and management of patients with primary biliary cholangitis;Hepatology International;2022-02

5. Chronic Liver Disease;Sex/Gender-Specific Medicine in the Gastrointestinal Diseases;2022